Search results

Found 245 pages
AUTHOR: Katrina Megget

Results per page

10 20 50 100

Sort by

Relevance Date

11 Dec 2008:

Biotech asks US Government for help

The Biotechnology Industry Organisation is asking the US Government for a financial stimulus for small biotech companies that are struggling during the credit crunch. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/biotech_asks_us_government_for_help_986188

28 Jun 2011:

Icagen shares jump amid Pfizer takeover speculation

Shares for Icagen jumped more than 120% yesterday after news the biotech firm was contemplating a deal with drug giant Pfizer. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/icagen_shares_jump_amid_pfizer_takeover_speculation_980805

7 Oct 2008:

Avastin/Tarceva combo does not improve survival

Genentech and OSI Pharmaceuticals have announced the combination treatment of Avastin (bevacizumab) with Tarceva (erlotinib) has not shown to improve survival in a Phase III study. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/avastintarceva_combo_does_not_improve_survival_986661

10 Sep 2009:

Pharma partly to blame for healthcare woes

As many as 84% of Americans blame the pharmaceutical industry for the country’s healthcare woes, a new survey has found. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/pharma_partly_to_blame_for_healthcare_woes_983672

4 Sep 2008:

Multaq cuts risk of stroke by a third

Sanofi-aventis’ potential blockbuster Multaq (dronedarone) has been shown to reduce the risk of stroke by more than a third in patients with an irregular heartbeat. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/multaq_cuts_risk_of_stroke_by_a_third_987934

2 Nov 2012:

Hurricane Sandy destroys medical research

Thousands of genetically engineered lab mice and years of research are believed to be the latest casualties following the fierce Hurricane Sandy that hit East Coast America this week. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/hurricane_sandy_destroys_medical_research_976316

12 Apr 2012:

Takeda buys gout company URL Pharma

Takeda has forked out $800 million to acquire US-based gout specialist URL Pharma in its bid to expand in the states – however, some analysts have found the deal baffling. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/takeda_buys_gout_company_url_pharma_977500

20 Aug 2010:

Date rape drug being considered by FDA

Despite GHB being a popular date rape drug, the US Food andDrug Administration has revealed it believes it to be effective in treatingfibromyalgia, say documents released ahead of today’s marketing review. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/date_rape_drug_being_considered_by_fda_982567

18 Sep 2008:

UK’s online research archive gets a facelift

The UK’s version of a digital archive of peer-reviewed research papers will be further developed after getting a cash injection of £1.3 million. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/uks_online_research_archive_gets_a_facelift_987837

13 Aug 2009:

Woodcock investigated for conflict of interest

The US Food and Drug Administration’s Janet Woodcock is under investigation for an alleged conflict of interest involving two generic drugmakers and approval of their drugs. - News - PharmaTimes

by Katrina Megget

www.pharmatimes.com/news/woodcock_investigated_for_conflict_of_interest_983825